Back to VG Vanguard Global Advisers, LLC
SGMOQ
2 quarters
Position history for VGVanguard Global Advisers, LLC's holdings in SANGAMO THERAPEUTICS, INC
As of its Q1 2026 13F, Vanguard Global Advisers held 154,061 shares of SGMOQ (Sangamo Therapeutics), worth $38,053.
Final Value
$0
Final Shares
0
Total Value Change
-$38,053
Total Shares Change
-154,061
Quarter-by-Quarter History
Other major holders of SGMOQ: Wasatch Advisors LP, State Street Corp., Wellington Management Group LLP